Soluble HLA levels in early pregnancy after in vitro fertilization

Human Immunology

Volumn 61, Issue 6, 2000, Pages 559-564

  Pfeiffer, Kerstin A ^a   Rebmann, Vera ^b   Pässler, Monika ^b   Van Der Ven, Kathrin ^a   Van Der Ven, Hans ^a   Krebs, Dieter ^a   Grosse Wilde, Hans ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Pregnancy immunology; SHLA Class I; SHLA class II; SHLA G

Indexed keywords

CHORIONIC GONADOTROPIN; HLA ANTIGEN; HLA DR ANTIGEN; HLA G ANTIGEN;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERTILIZATION IN VITRO; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; NORMAL HUMAN; OVULATION; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROGNOSIS;

ABORTION, SPONTANEOUS; BETA 2-MICROGLOBULIN; FEMALE; FERTILIZATION IN VITRO; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HLA-DR ANTIGENS; HUMANS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTERS; PREGNANCY, TUBAL;

EID: 0034083998     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(00)00123-3     Document Type: Article

References (28)

1. McDonald J.C., Adamashvili I. Soluble HLA a review of literature . Hum Immunol. 59:1998;387.
2. Zavazava N, Krönke M. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat Med. 2:1996;1005.
3. Webb B.J., Bochan M.R., Montel A., Padilla L.M., Brahmi Z. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum. Cell Immunol. 159:1994;246.
4. Carbone E., Terrazaano G., Colonna M., Tuosto L., Piccolella E., Franksson L., Palazzolo G., Perez-Villar J.J., Fontana S., Kärre K., Zappacosta S. Natural killer clones recognize specific soluble HLA class I molecules. Eur J Immunol. 26:1996;683.
5. Ditschkowski M., Kreuzfelder E., Rebmann V., Ferencik S., Majetschak M., Schmid E.N., Obertacke U., Schade U.F., Grosse-Wilde H. HLA-DR expression and soluble HLA-DR levels in sepsis patients after trauma. Annal Surg. 229:1999;246.
6. Filaci G., Contini P., Brenci S., Lanza L., Scudeletti M., Indiveri F., Puppo F. Increased serum concentration of soluble HLA-DR antigens in HIV infection and following transplantation. Tissue Antigens. 46:1995;117.
7. Ott M., Seidl C., Westhoff U., Stecker K., Seifried E., Fischer P.-A, Grosse-Wilde H. Elevated soluble HLA class II levels in the serum of multiple sclerosis patients indicate acute relapse and rapid progression of disease. Tissue Antigens. 51:1998;301.
8. Liem L.M., Koelman C.A., Doxiadis I.N., van Houwelingen J.C., Goulmy E., Claas F.H.J. Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease. Bone Marrow Transplant. 20:1997;227.
9. Zavazava N., Bötcher H., Müller-Ruchholtz W. Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients. Tissue Antigens. 42:1993;20.
10. Rebmann V., Pfeiffer K., Päßler M., Ferrone S., Weiss E., Grosse-Wilde H. Detection of soluble HLA-G molecules in plasma and amniotic fluids. Tissue Antigens. 53:1999;14.
11. Sanders S.K., Giblin P.A., Kavathas P. Cell-cell adhesion mediated by CD8 and human histocompatibility leukocyte antigen G, a nonclassical major histocompatibility complex class I molecule on cytotrophoblasts. J Exp Med. 174:1991;737.
12. Münz C., Holmes N., King A., Loke Y.W., Colonna M., Schild H., Rammensee H.G. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J Exp Med. 185:1997;385.
13. Hutter H., Hammer A., Blaschitz A., Hartmann M., Ebbesen P., Dohr G., Ziegler A., Uchanska-Ziegler B. Expression of HLA class I molecules in human first trimester and term placenta trophoblast. Cell Tissue Res. 286:1996;439.
14. King A., Boocock C., Sharkey A.M., Gardner L., Beretta A., Siccardi A.G., Loke Y.W. Evidence for the expression of HLA-C Class I mRNA and protein by human first trimester trophoblast. J Immunol. 156:1996;2068.
15. Kovats S., Main E.K., Librach C., Stubbeline M., Fisher S.J., deMars R.A. A class I antigen, HLA-G expressed in human trophoblasts. Science. 248:1990;220.
16. Tilg H., Westhoff U., Vogel W., Aulitzky W.E., Herold M., Grosse-Wilde H. Soluble HLA class I serum concentrations increase with transplant-related complications after liver transplantation. J Hepatol. 14:1992;417.
17. Pouletty C., Ferrone S., Amesland F., Cohen N., Westhoff U., Charron D., Shimizu R.M., Grosse-Wilde H. Summary report from the first international workshop on soluble HLA antigens Paris, August 1992 . Tissue Antigens. 42:1993;45.
18. Ober C., Aldrich C., Rosinsky B., Robertson A., Walker M.A., Willadsen S., Verp M.S., Geraghty D.E., Hunt J.S. HLA-G1 protein expression is not essential for fetal survival. Placenta. 19:1998;127.
19. Russwurm G.P., Mackler A.M., Fagoaga O.R., Brown W.S., Sakala E.P., Yellon S.M., Nehlsen-Cannarella S.L. Soluble human leukocyte antigens, interleukin-6, and interferon-γ during pregnancy. Am J Reprod Immunol. 38:1997;256.
20. 2-mikroglobulin in pregnant females and cord blood samples. Hum Immunol. 54:1997;63.
21. Doxiadis I., Westhoff U., Grosse-Wilde H. Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay. Blut. 59:1989;449.
22. DeVito-Haynes L.D., Jankowska-Gan E., Heisey D.M., Cornwell R.D., Meyer K.C., Love R.B., Burlingham W.J. Soluble HLA class I in epithelial lining fluid of lung transplants associations with graft outcome . Hum Immunol. 52:1997;95.
23. Pollard S.G., Davies H.F., Calne R.Y. Peroperative appearance of serum class I antigen during liver transplantation. Transplantation. 49:1990;659.
24. Puppo F., Scudeletti M., Indiveri F., Ferrone S. Serum HLA class I antigens markers and modulators of an immune response? Immunol Today. 16:1995;124.
25. Mueller-Eckhardt G., Heine O., Neppert J. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin. Vox Sang. 56:1989;151.
26. Coulam C.B., Krysa L.W., Bustillo M. Intravenous immunoglobulin for in vitro fertilization failure. Hum Reprod. 9:1994;2265.
27. Blasczyk R., Westhoff U., Grosse-Wilde H. Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations. Lancet. 341:1993;789.
28. Grosse-Wilde H., Blascyk R., Westhoff U. Soluble HLA class I and class II concentrations in commercial immunoglobulin preparations. Tissue Antigens. 39:1992;74.